BioNTech Sues Moderna for Patent Infringement Over COVID Shots
Insurance Journal - Feb 20, 2026
German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a patent related to BioNTech and Pfizer’s competing shot Comirnaty. The lawsuit said that mNEXSPIKE, Moderna’s next-generation...
Recommended Articles
Posted: Feb 20, 2026
Markel announced a new collaboration with Upfort to provide eligible U.S. cyber policyholders with a...
Posted: Feb 20, 2026
Amwins Appoints Yuko and Shapiro to Lead New Hospitality Practice Amwins, headquartered in Charlotte...
Posted: Feb 20, 2026
Live Nation Entertainment Inc. must face an antitrust trial on some claims brought by the US Justice...